Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib
Daichi Watanabe, Hironori Fujii, Yunami Yamada, Nobuhisa Matsuhashi, Akitaka Makiyama, Hirotoshi Iihara, Takao Takahashi, Shigeru Kiyama, Ryo Kobayashi, Kazuhiro Yoshida, Akio Suzuki
Topics & Concepts
MedicineRegorafenibInternal medicineHazard ratioIncidence (geometry)GastroenterologyColorectal cancerClinical endpointAdverse effectProportional hazards modelConfidence intervalCancerClinical trialPhysicsOpticsColorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and PrognosisBone health and treatments